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Abstract
Background:  The acetamidase of Mycobacterium smegmatis is a highly inducible enzyme.
Expression of this enzyme is increased 100-fold when the substrate acetamide is present. The
acetamidase gene is found immediately downstream of three open reading frames. Two of these
are proposed to be involved in regulation.
Results:  We constructed a deletion mutant in one of the upstream ORFs (amiA). This mutant
(Mad1) showed a constitutively high level of acetamidase expression. We identified four promoters
in the upstream region using a β-galactosidase reporter gene. One of these (P2) was inducible in
the wild-type, but was constitutively active in Mad1.
Conclusions:  These results demonstrate that amiA encodes a negative regulatory protein which
interacts with P2. Since amiA has homology to DNA-binding proteins, it is likely that it exerts the
regulatory effect by binding to the promoter to prevent transcription.
Background
The acetamidase enzyme of Mycobacterium smegmatis
is a highly inducible enzyme [1]. In the presence of a suit-
able substrate, such as acetamide, the enzyme is ex-
pressed to a high level, forming up to 10% of the total
protein. In the absence of an inducer the enzyme is ex-
pressed at a low (basal) level. Previous work has shown
that both positive and negative control elements are in-
volved in the regulation of the acetamidase. Induction
occurs at the transcriptional level with increased
amounts of acetamidase mRNA detectable after 1 hour
[2]. Three open reading frames have been identified im-
mediately upstream of the acetamidase gene (amiE in
Figure 1) and these have been proposed to encode two
regulatory genes (amiA and amiD) and a transport gene
(amiS) [2,3]. In addition, a third gene (amiC) which is
divergently transcribed has been proposed to be a regu-
latory protein [3] (Figure 1).
The lack of a suitable highly inducible promoter has hin-
dered research in the genetics of mycobacteria. The
acetamidase promoter is a good candidate for use in such
studies, but it is important to understand its regulation
in order to improve its utility.
The aim of this study was to determine what role one of
the proposed regulatory genes, amiA, plays in the regu-
lation of acetamidase expression. An unmarked deletion
mutant was constructed which lacked the amiA gene and
the effect on acetamidase expression was assessed. We
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for acetamidase expression. Previous work with a report-
er gene identified an inducible promoter within the re-
gion located approximately 1.5 kb upstream of the
acetamidase itself [3], although the possibility of more
than one promoter was not excluded. We used a β-galac-
tosidase reporter gene to assay for promoter activity in
the regions found immediately upstream of each gene.
Four promoters were identified and their activity was
measured in both the wild-type and amiA mutant
strains.
Results and Discussion
Mad1 shows constitutively high level expression of the 
acetamidase
In order to begin to determine the role of the upstream
genes in acetamidase expression, we constructed an un-
marked amiA∆ mutant strain and then assessed the ef-
fect on AmiE expression by SDS-PAGE analysis of cell-
free extracts (Figure 2). As has been previously shown
[1–3], wild-type extracts showed clear induction of the
47 kDa acetamidase protein in the presence of aceta-
mide. Mad1 showed a constitutively high level expres-
sion of AmiE. The identity of this protein was confirmed
as the acetamidase by Western blotting (results not
shown). Complementation with a functional copy of
amiA (Mad1:pAGAN303) restored the ability of the cells
to repress the acetamidase in the absence of an inducer.
Since the acetamidase is not repressed in the absence of
amiA, we conclude that it is a negative regulator of ex-
pression.
Multiple promoters are involved in acetamidase expres-
sion
Previous work has demonstrated that an inducible pro-
moter was located in the 1.4 kb region approximately 1.5
kb upstream of amiE[3], although the possibility of more
than one promoter was not excluded. In order to deter-
mine whether multiple promoters were involved in AmiE
expression, we cloned the regions immediately upstream
of each gene into a promoter probe vector carrying a β-
galactosidase reporter gene (Table 1 and Figure 3). These
constructs were first assayed for promoter activity in the
wild-type strain. Four inserts with promoter activity
were identified (Table 2). Pc drives the expression of
amiC and is active at a low, but constitutive level. P2 up-
stream of amiD is a stronger promoter which shows a
two-fold induction in the presence of acetamide (p <
0.012 using the students t-test). This is consistent with
the previous results which showed that a two-fold induc-
ible promoter was located in the 1.4 kb upstream region
[3] (although the exact location of the promoter was not
defined within this region). P1, upstream of amiA, had
the highest promoter activity, but was constitutive. P3 is
a very weak promoter found immediately upstream of
amiE itself, which could allow the transcription of a
monocistronic message encoding the acetamidase only,
whereas P1 and P2 are more likely to be responsible for
polycistronic messages. Northern blotting has previously
shown that a 1.2 kb acetamidase transcript is indeed
present (and induced) in the cells [3]. This could either
arise from P3 or from processing of mRNA transcribed
from P1 or P2.
Figure 1
Vector constructs. A: Arrangement of genes in the Mycobac-
terium smegmatis chromosome. amiA, amiC and amiD are pro-
posed regulators, amiS encodes one component of a putative
ABC transporter. amiE is the acetamidase gene. B: The two
fragments used to generate the delivery vector for construc-
tion of the amiA deletion mutant. The resulting SalI deletion
in the Mad1 strain is indicated which removes the majority of
the amiA gene. C: The region used to complement the Mad1
mutant.
Figure 2
Acetamidase expression in Mad1. Cell-free extracts were
electrophoresed though a 10 % acrylamide gel. Lanes are 1:
wild-type MM-S 2: Wild-type MM-AS 3: Mad1 MM-S 4: Mad1
MM-AS 5: Mad1/pAGAN303 MM-S 6: Mad1/pAGAN303
MM-AS 7: markers, size given in kDa. The acetamidase band
at 47 kDa is indicated. MM-S: minimal media with succinate.
MM-AS: minimal media with acetamide and succinate.
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contained all the regulatory sites normally present for
each promoter. This may explain why we did not isolate
a highly inducible promoter (only two-fold induction for
P2) and the fact that the P3 promoter seemed to be very
weak. Although we expected to find a highly inducible
promoter, it is possible that one does not exist and that
the induction of the acetamidase enzyme seen in the cell-
free extracts may be a result of other mechanisms, such
as an increase in mRNA stability.
There is a predicted consensus promoter sequence in the
P2 region which has both the -10 and -35 boxes of classi-
cal promoters [2]. None of the other promoter fragments
show any similarity to previously identified promoter
consensus sequences. Mycobacterial promoters often
have a different structure from the typical Escherichia
coli promoter [4,5], so this is not surprising. In addition,
regulated promoters often do not have strong consensus
sequences and rely on the presence of other regulatory or
accessory proteins to recruit RNA polymerase and initi-
ate transcription.
Promoter activity in Mad1
Three of the promoters were assayed for activity in the
amiA deletion strain (Figure 3 and Table 2). P1 promoter
activity was unaffected (Table 2). P2 activity was un-
changed under induced conditions, but was significantly
higher in the uninduced conditions (p < 0.02). The activ-
ity of Pc was also affected and was higher under both con-
ditions (p < 0.03). Thus AmiA appears to repress both Pc
and P2 promoters.
The role of AmiA
Taken together the data suggest that AmiA acts to re-
press the P2 promoter and thus prevent expression of the
acetamidase. Since AmiA shows homology to the MarA
DNA-binding group of regulatory proteins, it seems like-
ly that it would exert this effect by binding to the P2 pro-
moter region and preventing transcription.
Conclusions
We have demonstrated that acetamidase expression is
derepressed in an amiA deletion mutant and that of four
promoters identified, two show increased activity in this
strain. In light of this evidence we propose the following
model. In the absence of acetamide, AmiA binds to the P2
promoter region and prevents transcription of the three
genes downstream. The small basal level of acetamidase
expression arises from P2 leakage, or from the P3 pro-
moter. AmiA may also bind to the Pc promoter and re-
duce expression of AmiC. In the presence of acetamide,
AmiA no longer binds to the P2 promoter region and
transcription can then proceed at a higher level. In the
latter case, it is probable that AmiC, which has a probable
acetamide-binding domain [6], binds to both acetamide
and AmiA thereby preventing its interaction with the
promoters.
Figure 3
Promoter activity assays. The fragments assayed for pro-
moter activity are shown, with arrows indicating the direc-
tion of the fragment realtive to the β-galactosidase gene. The
pAGAN construct series numbers are given below each
arrow. The four identified promoter fragments (Pc, P1, P2
and P3) are labelled and indicated by thicker arrows.
Table 1: Promoter assay constructs.
pAGAN pJEM Primer Primer PCR product
number number name sequence position
120/121 12 PACT4 GGATCCATCTACCGGACTGCC 1677–1986
PACT5 GGATCCGAAGGGACCGCAGTG
130/131 14/13 PACT6 GGATCCACCAGCCCGACG 1291–1536
PACT7 GGATCCTGAGCGACGAGT
160/161 13 PACT10 GGATCCCCGAGCGCGATG 2000–2254
PACT13 GGATCCACGTAGAAGAGC
170/171 12 PACT9 GGATCCCTCCTTGCACTC 2758–3026
PACT12 GGATCCCGCCGTGATCGG
The regions shown in figure 3 were PCR-amplified from genomic DNA and cloned into pGEM-T (Promega). Primers were designed to contain BamHI 
sites at each end. The fragments were then excised as BamHI fragments and cloned into one of the pJEM vectors to give in-frame fusions to the 
promoterless β-galactosidase gene. The position of the PCR product with respect to the complete acetamidase region is given (assembled from 
Accession numbers U63095 and X57175).
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used for genetic manipulation of mycobacteria [7–9], in-
cluding over-expression of heterologous proteins, the
system is far from ideal. Thus the characterisation of the
role of amiA is an important step towards our under-
standing of the system and will allow the construction of
more sophisticated systems in the future.
Material and Methods
Media
M. smegmatis was grown in Lemco medium (5 g/L Lem-
co powder, 5 g/L NaCl, 10 g/L Bacto peptone) with 0.05
% Tween 80 (liquid) or 15 g/L Bacto agar (solid). Kan-
amycin was added to 20 µg/ml, hygromycin to 100 µg/
ml, gentamicin to 10 µg/ml and sucrose to 5% where ap-
propriate. Minimal media [2] contained 0.05% Tween
80 and carbon sources (acetamide or succinate) at
0.02%.
Construction of deletion mutant strain Mad1
A suicide (non-replicating) delivery vector (pURR541)
was constructed using a rapid cloning system [10]. First,
the 1.4 kb BamHI-SalI and 0.5 kb SalI-PstI fragments
indicated in Figure 1 were cloned into the manipulation
vector p2NIL. The sacB and hyg marker genes were then
cloned in as a PacI fragment from pGOAL13 [10]; these
confer sucrose sensitivity and hygromycin resistance re-
spectively. The final delivery vector also had a kanamy-
cin resistance gene. M. smegmatis Mad1 was
constructed using a two-step strategy. The delivery vec-
tor pURR541 was electroporated [11] into M. smegmatis
mc2155 and single crossovers selected on hygromycin,
kanamycin plates. One such transformant was streaked
out to allow the second recombination event to occur.
Double crossovers were identified by selecting for su-
crose resistance and screening for kanamycin and hygro-
mycin sensitivity. Southern blotting was used to
determine which of the double crossovers had the wild-
type genotype restored and which had the amiA deletion
in the chromosome.
Complementation of Mad1
The complementing vector pAGAN303 was constructed
by PCR-amplifying the amiA gene (Figure 1) using prim-
ers which were designed to contain EcoRI restriction
sites. The PCR fragment was cloned as an EcoRI frag-
ment into integrating vector pINT3 which carries the
mycobacteriophage L5 integrase and attachment sites
and a gentamicin resistance gene. Mad1 was electropo-
rated with this plasmid and transformants selected on
gentamicin.
Preparation of cell-free extracts
Strains were grown overnight in 5 ml Lemco broth and
used to inoculate 100 ml of minimal media plus either
acetamide and succinate (MM-AS) or succinate alone
(MM-S) and incubated for 24 hours. Bacteria were har-
vested, washed and resuspended in 1 ml of 10 mM Tris-
HCl pH 8. An equal volume of 0.1 mm glass beads were
added and the suspensions subjected to 2 × 1 min pulses
in the MiniBead Beater (Biospec Products). Cell debris
was removed by spinning at 13000 g for 5 min.
Promoter activity assays
Promoter constructs (Table 1 and Figure 3) were electro-
porated into M. smegmatis and transformants selected
with kanamycin. For each construct three transformants
were grown up in 5 ml Lemco and used to inoculate 5 ml
of MM-AS or MM-S. Cultures were incubated for 24, har-
vested, washed once and resuspended in 1 ml of 10 mM
Tris-HCl pH8. Cell lysates were prepared by sonication
with a 3 mm microprobe at 20% amplitude for 30 sec-
onds using an Ultrasonic Processor (Sonics and Materi-
al). β-galactosidase activity was measured as previously
described [12].
Table 2: Promoter activity assays.
Wild-type Wild-type Mad1 Mad1
Construct Promoter MM-S MM-AS MM-S MM-AS
pAGAN120 P2 110 ± 34 169 ± 40 332 ± 110 301 ± 256
pAGAN130 P1 705 ± 151 671 ± 109 970 ± 278 1079 ± 444
pAGAN131 Pc 20 ± 2.4 22 ± 6.8 41 ± 17 86 ± 46
pAGAN170 P3 2.4 ± 0.5 4.1 ± 1.2 nd nd
pJEM control none 0.8 ± 0.4 1.3 ± 0.1 1.3 ± 0.2 2.2 ± 1.5
The constructs from figure 3 were assayed for β-galactosidase activity in both the wild-type and Mad1 strains. Values represent the mean ± standard 
error of six values from three independent transformants and are expressed as nmol O-nitro phenyl galactoside produced per min per mg total 
protein. Constructs pAGAN121, 160, 161 and 171 were all negative. nd – not determined.
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